Significantly increased IP-10/CXCL10 expression in both corneal and conjunctival epithelium has been described in an experimental animal model of dry eye [61] and more recently in tears from Sjögren Syndrome DED patients, and also, but non significantly, in non-Sjögren DED patients [51]. Here, CXCL10 is linked to Sjogren syndrome.